liqingzhao(清远)
Feb-17-22 | Reiterated | Wolfe Research | Outperform | $1500 → $1100 |
|
Feb-17-22 | Reiterated | Wedbush | Outperform | $1270 → $937 |
|
Feb-17-22 | Reiterated | TD Securities | Hold | $1500 → $840 |
|
Feb-17-22 | Reiterated | Stifel | Buy | $1300 → $1000 |
|
Feb-17-22 | Reiterated | Robert W. Baird | Outperform | $1650 → $1000 |
|
Feb-17-22 | Reiterated | RBC Capital Mkts | Outperform | $1450 → $1300 |
|
Feb-17-22 | Reiterated | Piper Sandler | Overweight | $1400 → $900 |
|
Feb-17-22 | Reiterated | Oppenheimer | Outperform | $1350 → $960 |
|
Feb-17-22 | Reiterated | Morgan Stanley | Equal-Weight | $1150 → $1075 |
|
Feb-17-22 | Reiterated | Mizuho | Neutral | $900 → $800 |
|
Feb-17-22 | Reiterated | Loop Capital | Hold | $1300 → $800 |
|
Feb-17-22 | Reiterated | Jefferies | Buy | $1800 → $1350 |
|
Feb-17-22 | Reiterated | Goldman | Neutral | $1570 → $833 |
|
Feb-17-22 | Reiterated | Evercore ISI | Outperform | $1770 → $1000 |
|
Feb-17-22 | Reiterated | Deutsche Bank | Hold | $1400 → $900 |
|
Feb-17-22 | Reiterated | Credit Suisse | Neutral | $1300 → $850 |
|
Feb-17-22 | Reiterated | Citigroup | Neutral | $978 → $882 |
|
Feb-17-22 | Reiterated | Canaccord Genuity | Hold | $1450 → $800 |
|
Feb-17-22 | Downgrade | ROTH Capital | Buy → Neutral | $1400 → $850 |
|
(#191409@43)
Last Updated: 2022-2-18